The viral latent membrane proteins 2 (LHP2) of Epstein-Barr virus (EBV) were analysed genetically to evaluate their role in B cell immortalization. LHP2 is transcribed as two differently spliced mRNAs which code for the LHP2A and -B proteins, also called terminal protein-1 and -2. LHP2A and -Bare found in latently infected, growth-transformed B lymphocytes in vitro, in different human tumours, and in latently infected B cells in vivo. Two different approaches were used to generate EBV mutants in which the second, third and part of the fourth exon of the LHP2 gene were deleted by insertion of a marker gene. Initially, conventional homologous recombination in a Burkitt's lymphoma cell line (P3HR1) between the endogenous EBV genome and an introduced plasmid was used to generate EBV mutants. This experiment identified LMP2 as dispensable for B cell immortalization as has been reported. In a second approach, the same LHP2 mutant gene was analysed in the context of a mini-EBV plasmid. These are E. coil constructs that are sufficient when packaged into an EBV coat both to initiate and to maintain proliferation of infected B cells. In comparison with a fully competent mini-EBV, LHP2-mini-EBVs were found to be greatly reduced in their capacity to yield immortalized B cell clones. This finding confirmed the initially observed bias against LHP2-B cell clones, most of which were found to be coinfected with complementing P3HR1 virus. These results indicate that LHP2 contributes to the efficiency of B cell immortalization and that the LHP2s phenotype is auxiliary in nature.
Introduction
Epstein-Barr virus (EBV) is a herpesvirus which is associated with a variety of malignancies that include B cell lymphomas in immunocompromised patients, Burkitt's lymphoma, certain T cell lymphomas, most cases of Hodgkin's disease and nasopharyngeal carcinoma (for review see Liebowitz & Kieff, 1993 ; Sugden, 1995) . It was the first human tumour virus to be identified. EBV also infects resting human primary B lymphocytes and induces and maintains the proliferation of these B cells in vitro, a process called immortalization. Immortalized B cells are latently infected with EBV and only 11 out of ~ 80 viral genes are expressed in these cells. Some of the viral genes which are consistently found in immortalized B cells are also expressed in certain EBVassociated human tumours. Therefore, B cell immortalization by EBV is the in vitro model system for the contribution of this tumour virus to proliferative diseases. Wolfgang Hammerschmidt. Fax + 49 89 7099 500. e-mail hammers@gsf.de Three of the 11 viral proteins which are expressed in EBVimmortalized B cells in vitro localize to the plasma membrane and are called latent membrane protein-I, -2A and -2B (LMP1, LMP2A and LMP2B). LMP2A and LMP2B, which are also called terminal protein-1 and -2 (TP1 and TP2), are expressed from mRNAs that are formed by transcription and splicing across the joined termini of the circularized EBV genome as it is present in latently infected cells (Laux et al., 1988 (Laux et al., , 1989 Sample eta] ., 1989). The gene structure of LMP2A and LMP2B consists of unique and common exons (Fig. 1) . The common exons code for a highly hydrophobic protein which is predicted to form 12 transmembrane spanning domains reminiscent of transporter proteins (Laux et al., 1988) . The additional first exon of LMP2A generates a presumable cytoplasmic hydrophilic domain which is missing in LMP2B. LMP2A but not LMP2B is detectable in B lymphocytes isolated from peripheral blood of EBV seropositives (Qu & Rowe, 1992) and LMP2 transcripts as well as antibodies against the proteins have been detected in patients with nasopharyngeal carcinoma (Brooks et al., 1992; Busson et al., 1992 Busson et al., , 1995 Frech eta]., 1990 Frech eta]., , 1993 genome which removes the complete EBNA2 gene is depicted. The location of the three probes which were used in Southern blot hybridization is shown.
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LMP2 associates with LMP1 and these proteins have a rapid turn-over rate which suggests a role in receptor-mediated signal transduction (Baichwal & Sugden, 1988 , Martin & Sugden, 1991a Rowe eta] ., 1990). The amino-terminal part of LMP2A, which is encoded by its unique first exon, is associated with src family protein tyrosine kinases (Burkhardt et a[., 1992; ., 1991). LMP2A serves as a substrate for these protein kinases and acts as a dominant negative regulator of [yn and fyn protein kinase activity (Miller et aI., 1995) . Thereby, LMP2A interferes with signal transduction in that it blocks calcium mobilization following crosslinking of cell-surface immunoglobulin molecules and impairs tyrosine phosphorylation of other cellular protein substrates and second messenger generation (Miller eta]., 1993 (Miller eta]., , 1994 .
It is believed that these biochemical characteristics of LMP2A are indicative of a role in blocking induction of the lyric phase of the EBV life-cycle (Miller et aI., 1994 (Miller et aI., b, 1995 .
Despite these important biological characteristics genetic analyses have not revealed any phenotype for several mutations in LMP2A or LMP2B (Kim & Yates, 1993; Longnecker eta]., 1992 Longnecker eta]., , 1993 . The genetic data suggested that LMP2A and LMP2B are both dispensable for B cell immortalization and lytic functions of EBV. The technique which was used to generate mutant viruses, however, relies on fortuitous recombination between endogenous EBV DNA and plasmid DNA which is transiently introduced into latently EBV infected cells and carries the desired mutation. To promote recombination and release of virus, the lyric phase of the EBV life-cycle is concomitantly induced and the supernatant from these cells is harvested as a mixed virus stock that contains parental endogenous virus and a small proportion of recombinants whose structure is not known a priori. These stocks are used to immortalize B cells and the structure of the recombinant EBV DNA in them is analysed. This approach can only identify viral information sufficient to maintain proliferation of B cells (Cohen eta[., 1989; Hammerschmidt & Sugden, 1989; Mannick et a]., 1991; Marchini eta[., 1991 Marchini eta[., , 1992 Tomkinson & Kieff, 1992) . This approach cannot identify information sufficient to initiate B cell immortalization since the initial infecting virus is not known and may be lost during propagation of the cell (Kempkes et al., 1995 b) .
To identify viral information crucial for initiation of B cell immortalization, the immortalized cells are induced to release recombinant virus which is subsequently used to infect primary B lymphocytes. If recombinant virus alone is able to immortalize B cells it is concluded that the recombinant virus is sufficient to induce proliferation as well as to maintain it. The disadvantage of this approach is that the amount of recombinant virus is so low that the efficiency of B cell immortalization cannot be determined.
To overcome this limitation we have developed a different approach which uses mini-EBV plasmids with the capacity to carry all the information needed to initiate and maintain B cell immortalization in vitro (Kempkes eta] ., 1995 a, b). We used a single LMP2 mutation which affects both LMP2 proteins and tested this mutation in two different experimental settings for its effect on B cell immortalization. The mutation of the LMP2 (O'Connor et al., 1989) . The basic building strategy relies on an initial F-factor-based plasmid which is used as a recipient to add pieces of DNA by a combination of homologous and sitespecific recombinations in E. coll. The sequential addition of partially overlapping DNA segments of about 10 to 20 kb in length, which are molecularly cloned on a so-called shuttle plasmid, results in a stepwise increase in size of the primary F-factor plasmid. The approach allows an F-factor construct of defined composition to be built and also permits the final plasmid to be modified at all positions by homologous recombination in E. coil The modification technique is called 'crossing on mutations'.
Four partially overlapping fragments derived from the immortalization-competent B95.8 strain of EBV were cloned in E. coli, resulting in plasmid p1189.19 (Table I) , by the chromosomal building strategy (O'Connor et al., 1989) . p931.12 was the first F-factor-based plasmid which served as recipient for the sequential addition of the consecutive plasmids p935.1, p1177.3 and p927.3 (Kempkes et al., 1995 b) . The joined parts of the plasmid p1189.19 constitute 37 kbp of genomic EBV DNA and span from nucleotide position #163477 to #56081 with a gap between #19359 and #43935. This gap removes eight of twelve complete internal repeats (IR).
Construction of p40. To introduce a mutated LMP2 locus into p1189.19 the 'crossing on mutations' method (O'Connor el al., 1989) was used. First, the shuttle plasmid p34 was constructed: this carries the LMP2-locus flanked by EBV sequences, p34 contains the BamH] het fragment from nucleotide coordinate #166614 to #3955 of the B95.8 sequence (Baer et al., i984; Sugden et al., 1984) cloned into pMBO96 (O'Connor et al., 1989) . The EcoRI-SalI fragment from nucleotide coordinate #2 to #644 of the B95-8 sequence was replaced in p34 by a BamHI-SalI fragment derived from plasmid pHEBo with the hygromycin phosphotransferase gene in the context of regulatory sequences from the thymidine kinase gene of herpes simplex virus (Yates et al., 1985) (Fig. 1) . The p34 shuttle plasmid, which carried the desired LMP2-locus, was recombined with the parental p1189.19 Fplasmid to yield a cointegrate (Fig. 2) . This construct was finally resolved to yield the LMP2-plasmid p40, which is identical to the wildtype plasmid p1189.19 except for the LMP2 gene (Fig. 2) .
Construction of the mini-EBV plasmids p1478.A and p68. Starting with p1189.19 as F-factor recipient, the mini-EBV plasmid p1478.A was assembled in three additional basic building steps with the plasmids p948.27, p1470.1 and p1202.1 (Table 1 ). The p1478.A mini-EBV plasmid ( Fig. 3 ) contains all EBV genes known to be required to initiate and maintain B cell immortalization by EBV in vitro (Fan:ell, 1995; Kempkes et al., 1995 a, b) . Starting with p40 as the recipient, plasmid p68 ( Fig. 3) was assembled with the aid of the same three shuttle plasmids as were used for construction of the mini-EBV plasmid p1478.A, p68 carries the LMP2-mutation whereas p1478.A is wildtype. All intermediate plasmids and the final constructs were carefully checked by restriction enzyme analysis for the desired structures. With the exception of E. coli strain DHS~, which was purchased from Gibco BRL Life Technologies, all the cloning vectors and E. coli strains were obtained from M. O'Connor (O'Connor el al., 1989) . Table 1 . Composition of plasmids used to assemble p1189.19, p40 (LMP2-), p1478.A and p68 (LMP2-) mini-EBV plasmids
The names of plasmids and the nucleotide coordinates of the EBV inserts are given together with the restriction enzyme sites used for subcloning B95.8 DNA. The genes and cis-acting elements pertinent to this study are indicated. The cloning vector pMOB96 was used for all shuttle plasmids. The first construct in the chromosomal building process was p931.12, which is based on pMBO132 (Kempkes et aL, 1995a, b; O'Connor eta] ., 1989).
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Plasmid From # (cut) to # (cut) • Cell line and packaging procedures. HH514 is a bet-free cell clone of the P3HR1 Burkitt's lymphoma ceil line (Heston et al., I982; Rabson et al., 1982) and was grown in RPMI medium supplemented with 10 % fetal calf serum. To generate recombinant virus or to package mini-EBV plasmids, 1 x 107 HH514 cells were transiently transfected by electroporation (Bio-Rad Electroporator; 0"4 cm wide cuvettes, 250 p] volume, 960 p.F capacity, 240 V voltage) with 10 ,g of an expression vector for the viral BZLF1 gene (pCMV-BZLF1) (Hammerschmidt & Sugden, 1988) and 10 ,g of mini-EBV plasmid DNAs p40, p68, p1478.A or p1495.4. Cells were cultivated in lOml of medium and the supematant was harvested after 4 to 6 days. Primary human B cells prepared from cord blood were infected with virus stocks from the transiently transfected HH514 cells and plated at limiting dilution in 96-well cluster plates on a lethally irradiated human fibroblast feeder cell layer (MRC 5 cells; ATCC). To determine the efficiency of B cell immortalization by different virus stocks, adult peripheral B lymphocytes were purified by magnetic cell sorting with anti-CD I9 microbeads according to the manufacturer's protocol (Miltenyi Biotech Inc.). B cells (8 x I0 ~) were exposed to 8 ml of the virus stocks for 4 h at room temperature and subsequently plated in agarose as described (Sugden & Mark, 1977) . Colonies with 50 or more cells were scored approximately 21 days after plating. As a positive control supernatants from B95.8 cells were used which yielded 30000 or 55000 co[onies/ml in two independent experiments.
• PCR analyses and Southern blot hybridization. 83 , PO 0688b p
Maps of p1478.A wild-type mini-EBV plasmid and its p68 LMP2-derivative. The circularized map of both plasmids is shown with the BamHI sites schematically indicated on the inner circle. The 11 viral genes (EBNA1, EBNA-LP, EBNA2, EBNA3a to EBNA3c, LMP1, LMP2A and LMP2B, EBER1 and -2), generally expressed in immortalized B cells in vitro are either denoted as grey boxes together with the extension of the primary RNA transcripts (dashed lines) and promoters (--*) or are too small to be presented (EBER1 and -2). The three cis-acting elements involved in DNA replication and maturation of EBV are indicated by black boxes: the latent origin of DNA replication (oriP) , the lyric origin of DNA replication (oriLyt) (Hammerschmidt & Sugden, 1988) and the cleavage and packaging signals (TR) (Hammerschmidt & Sugden, 1989) . The prokaryotic plasmid backbone from the F-factor plasmid pMB0132 is indicated (O'Connor et al., 1989) . The insertion of the gene encoding hygromycin phosphotransferase (hyg) in the p68 mini-EBV plasmid disrupts both LMP2A and LMP2B gene products.
tinguish between wild-type P3HR1 virus and LMP2 mutant virus. The first primer pair was used to amplify 245 bp of P3HRI DNA corresponding to nucleotide position #214 to #458 of the B95.8 strain sequence. The latter primer pair detected a 253 bp DNA fragment specific for the mutated LMP2 genes spanning the junction of normal and mutated sequences as shown in Fig. I . Southern blots of ceIlular DNAs were prepared as described (Hammerschmidt & Sugden, 1988) . The Southern blots were probed with molecularly cloned EBV fragments (positions refer to nucleotide coordinates of the B95.8 strain of EBV) or plasmid DNAs (Figs I and 5 a).
Probe 1. To detect the prokaryotic plasmid backbone of the different mini-EBV DNAs, the F-factor plasmid DNA of pMBOI32 was used (O'Connor et al., 1989) .
Probe 2. The SalI-EcoRI fragment from #644 to #4163 was used for the blots shown in Figs 4 (a) and 5 (b).
Probe 3. A pUC plasmid carrying the DraI EBV fragment from #44769 to #50305 was used for the blot shown in Fig. 4(b) .
Probe 4. The HindIII fragment ranging from #82082 to #87237 of the B95.8 strain cloned on a pACYC vector was used for the blots shown in Fig. 5 (a) .
Results
Homologous recombination yields immortalized LHP2 B cell clones at low frequency
The conventional strategy to produce recombinant EBV is based on homologous recombination events between the endogenous EBV genome of the Burkitt's cell line P3HR1 and introduced plasmid DNA. The P3HRI cell line carries a viral DNA in which a portion of EBNA-LP and all of EBNA2 are deleted such that the endogenous DNA when amplified and packaged yields an immortalization-defective EBV also called P3HR1 (Bornkamm et al., 1980; Jeang & Hayward, 1983) . Plasmid DNAs with homology to EBV can be introduced into P3HR1 cells, the lyric cycle of the endogenous EBV induced by cotransfection of an expression vector for the viral BZLF1 gene (Countryman & Miller, 1985; Takada et al., 1986) , and recombination between the introduced DNAs and EBV D N A takes place. The virus stock harvested from these cells is mixed; it is composed of the parental endogenous virus, and recombinations between it and the introduced DNAs if they contain the terminal repeats (Hammerschmidt & Sugden, 1989) . P3HR1 virus alone is deficient for B ceil immortalization owing to a deletion which removed part of the EBNA-LP and all of EBNA2 gene (Bornkamm et al., 1980; Jeang & Hayward, I983) . This fact allows selection for recombinant virus by transfecting the sequences deleted in P3HR1 on one plasmid together with the DNA carrying the mutation to be introduced on a second plasmid and selecting for immortalizing virus after infection of susceptible B cells. Earlier studies have shown that about 5 to 10 % of the immortalizing (EBNA2 +) virus genomes also carry the mutation at the desired locus (Kim & Yates, 1993 
In order to increase the frequency of EBNA2 + and LMP2-EBV recombinants plasmid p40 was constructed; this contains the mutated LMP2 locus and the sequences deleted in P3HRI virus on a single plasmid in their genomic context (Fig. 1) (Bloss & Sugden, 1994) . p40 was cotransfected with an expression plasmid for BZLF1 (pCMV-BZLF1) (Hammerschmidt & Sugden, I988) into the HH514 cell line, a P3HR1 clone, pCMV-BZLF1 is able to induce the lyric cycle of the endogenous P3HR1 virus, which supports amplification of the transfected oriLyt-conraining vector along with the endogenous EBV DNA. The supernatant of these cells contains a mixture consisting of P3HR1 helper virus, packaged p40 and different recombinants between P3HR1 virus and the transfected p40 DNA. This virus stock was used to infect primary B cells which were then seeded on irradiated fibroblast feeder layers in 96-well plates at limiting dilutions. Immortalized single-cell clones were analysed by PCR and Southern blot hybridizations to evaluate the infecting viruses retrospectively.
Four independent experiments yielded a total of 128 cell clones, I I4 of which were further investigated by PCR analysis for the status of the LMP2 gene. About one-half of the clones were found to contain the insertional mutagen (data not shown). Seventy randomly selected B cell clones were analysed in Southern blot experiments for the presence of helper virus and for the characteristics of EBV recombinant virus. The results allowed the B cell clones to be grouped into five of six expected categories (Table 2) . Thirty-seven clones were doubly infected with helper virus and p40 mini-EBVs (category E). In the remaining 33 clones various recombinants between both DNAs were detected. Three B cell clones (E109, El10 and E129 in category A) were found to contain only the desired recombinant EBV DNA with the mutated LMP2 locus, whereas ten clones carried the same recombinant viral genome in conjunction with P3HR1 helper virus DNA (category C). Clones in category B carried a wild-type LMP2 gene and were infected with a single EBV recombinant in which only the deletion in P3HRI had been healed, presumably as a result of a double recombination event between P3HR1 and p40 DNA. No clones were found which resulted from coinfection with P3HR1 and LMP2+,EBNA2 + recombinant virus (category D).
No attempt was made to characterize the mutant virus DNA in four clones which seemed to be infected with heavily rearranged EBV genomes.
The clones E109, EI10 and E129 were further investigated in detail by Southern blot hybridization with EcoRI-and BamHI-digested cellular DNAs using various probes (Fig. 4) .
The desired composition could be confirmed in that all three clones showed the 3"7 kb EcoRI fragment specific for the mutated LMP2 locus and lacked the fragment specific for the wild-type gent (Fig. 4a, bottom panel) . The BamHI H and Y fragments were clearly detectable, which is indicative of the EBNA2 locus in p40 or B95.8 virus (Fig. 4 b) , and the clones were free of helper virus DNA as indicated by the absence of the BamHI O' fragment (Fig. 4 b) . These clones also lacked the fragment indicative of a transcomplementing p40 genome (Fig.  4 a, top panel) . Once established the phenotype and behaviour of the LMP2-B ceil clones were not grossly different from B cell lines immortalized by wild-type EBV with respect to growth kinetics and gene expression (data not shown).
Our data indicate that faithful recombination between P3HRI virus DNA and p40 plasmid DNA could be observed in about 40 % of the clones (13 out of 29) which were infected with recombinant virus. This finding supports the overall strategy of combining EBNA2 and the mutation to be introduced on one molecule. However, only three out of I3 clones (categories A and C) carried the desired mutation in the absence of helper virus. Very much in contrast, none of the LMP2+,EBNA2 + clones in category B in which only the deletion in the P3HRI gene was healed were coinfected with P3HR1 virus. This finding could mean that an LMP2-EBV is severely affected in its capacity to immortalize B cells efficiently since the majority of cells infected with LMP2-EBV carried a transcomplementing P3HR1 virus.
Table 2. Summary of results of Southern blot hybridizations of sincjle-cell B cell clones obtained with p40-containincj virus stocks
The composition of 70 different B cell clones with respect to the genes LMP2 and EBNA2 in recombinant EBV, coinfecting P3HRI helper virus (LMP2+,EBNA2) and p40 (LMP2 ,EBNA2 +) are summarized and grouped into categories. Table 2 . The lane indicated 'p40' serves as a control for the mutated 3.7 kb EcoRI fragment and the 4.2 kb fragment detected in P3HR1 cellular DNA indicates the situation for the wild-type LMP genes. Three clones (El 09, E110 and E129) carry a recombinant LMP2 genome as indicated by the lack of a signal indicative of the p40 plasmid backbone in the top panel and the presence of the mutated LNIP2 gone in the lower panel. Cell lines E35, E39, E40 and E61 show the 26-9 kb fragment and the heterogeneous terminal fragment in the upper panel with probe 1 and therefore contain p40 DNA plus transcomplementin 9 P3HR1 virus. (* Cell line E61 contains a very small amount of p40 DNA which is not visible on this exposure of the autoradiogram. ) This findin 9 was confirmed by the presence of two EcoRI fragments for the wild-type and mutant LMP2 allele detected by probe 2 in the lower panel. In cell line E61, the signal specific for p40 plasmid DNA is weak but visible. These cell lines belong to category E (Table 2 ). E32 and E43 contain no detectable p40 DNA (upper part) and only wild-type LMP2 (lower part) and belong to category B. Cell line E128 contains additional non-characterized fragments as shown in (b) and is an example of an uncharacterized EBV recombinant ('others' in Table 2 
Genotype of B cell clones
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Immortalization efficiency of LMP2-mini-EBV plasmid is greatly reduced
The initial approach to study LMP2 genetically relied on recombination between endogenous EBV DNA and a newly introduced plasmid to generate LMP2 EBV mutants. This approach is limited since recombination events yield a variety of progeny whose contributions to immortalization can only be assessed retrospectively. Moreover, this approach does not allow ready measurements of quantitatively distinct contributions to the overall process. To overcome these limitations mini-EBV plasmids were constructed which encompass all the EBV genes necessary and sufficient for efficient B cell immortalization (Kempkes eta] ., 1995 a, b). When packaged by an endogenous P3HR1 helper virus (or transfected into B cells as plasmid DNA) these piasmids alone can initiate and maintain proliferation of infected primary human B lymphocytes.
To quantify the effect of LMP2 mutations, two mini-EBV plasmids were constructed, differing only in their LMP2 loci (Fig. 3) . The wild-type plasmid and the LMP2-mutant plasmid, termed p1478.A and p68, respectively, encompass the latent and lyric origins of DNA replication, oriP and oriLyt, the packaging signal sequences TR, and all the genes known to be expressed in EBV-immortalized B cells (Table 1) . p1478.A is a parental construct of the mini-EBV plasmid pi495.4 which, once packaged, can infect primary B lymphocytes and initiate and maintain proliferation (Kempkes et aI., I995a) . p1478.A and p68 are 81760 bp and 83014 bp in size including the prokaryotic plasmid backbone and are identical with the exception of hyg inserted into the LMP2 locus of p68 (Fig. 3) . The LMP2 mutation in p68 is the same as in the previous experiment. The sizes of both p1478.A and p68 are ideal for optimal packaging into an EBV coat as a dimer (Bloss & Sugden, 1994) and the mutation present in p68 is not expected to affect packaging efficiency (Zimmermann & Hammerschmidt, 1995) . p1478.A and p68 were both packaged in the PdHR1 helper cell line as described (Kempkes et al., 1995 b) . Adult peripheral B lymphocytes were exposed to dilutions of the virus stocks and the infected cells were plated in semi-solid medium on irradiated fibroblast feeder cells. The number of proliferating colonies was counted after they had accumulated to more than about 50 cells. Virus stocks with packaged p1478.A mini-EBVs gave 48 and 113 clones, whereas p68 mini-EBV stocks generated only two and eleven clones in two independent experiments. Uninfected B cells or cells infected only with helper virus did not yield any clones.
B cell clones infected with virus stocks containing packaged p68 or p1478.A were obtained in additional experiments in which primary B cells were exposed to dilutions of virus stocks containing p68 or pI478.A mini-EBVs. Fifty-six single-cell B cell clones infected with p68 virus stocks were analysed in Southern blot hybridizations to investigate the status of their virus DNA. Total cellular DNAs were restricted with EcoRI and the resulting blots were probed with the prokaryotic vector backbone of the mini-EBV plasmids. Fifty-four out of 56 clones derived from a number of independent experiments were found to carry p68 mini-EBV DNA (data not shown). The two remaining clones presumably were recombinants between p68 and helper virus in which the P3HR1 deletion was healed. These two clones were not further analysed.
B cells infected with virus stocks containing wild-type mini-EBV-like p 1478.A generate B cell clones readily with single-hit dose-response kinetics indicating that a single particle of virus is sufficient to induce and maintain proliferation (Kempkes et al., 1995 b ; data not shown). As a consequence, the majority of the cells are found to be free of PdHRI helper virus and contain the mini-EBV genome only. To explore the status of PdHR1 helper virus in the cell clones obtained with p68 virus stocks, a probe was used which is able to distinguish between the two DNAs. Two clones (clones 29/1 and 22/14 in Fig. 5a ) out of 52 contained p68 DNA only; the remaining cells were found to be coinfected with helper virus. To analyse the LMP2 gene for its specific hyg insertion in the two helper virus free cell lines, EcoRI-restricted cellular DNAs were hybridized to a radioactively labelled probe. To our surprise, EcoRI fragments were detected which are specific for both the mutant and the wild-type locus in the two ceil lines 29/1 and 22/14 (Fig. 5 b) . Since the p68 mini-EBV plasmid is packaged as a dimer, the result indicated that recombination between PdHR1 and p68 DNAs in the packaging cell line had restored one of the two LMP2 alleles of the p68 dimeric genome. Alternatively, recombination between p68 and PdHR1 in coinfected B cells restored an LMP2 locus on p68 and the P3HR1 genome was subsequently lost. Together, these findings suggest that LMP2-mini-EBVs are severely crippled in their capacity to yield immortalized B cells in vitro.
Discussion
The results of this study indicate that the LMP2 gene plays a critical role in the efficiency of B cell immortalization. The LMP2 gene is not absolutely required for EBV to immortalize p40. In lane P3HR1 fragments H and Y are missing and replaced by the fragment O' owing to the deletion in the P3HR1 helper virus genome, Cell lines E109, E110 and E129 contain only p40 fragments and no detectable BomHI Q' fragment indicating the absence of the P3HR1 helper virus DNA. These data together with the autoradiograms shown in (a) (and additional Southern blot hybridizations; not shown) indicated that these three cell lines contain recombinant EBV DNA in which p40 had healed the deletion in the P3HR1 genome and replaced the wild-type LMP2 genes by its mutant allele. Cell line E61 carries bands specific for helper virus and p40 DNAs and is infected with both viruses. The weak signal of the Q' and vector fragments indicates the ratio between helper virus and p40 DNA. Cell line E128 contains additional uncharacterized fragments, Sizes of bacteriophage ,1 Hindlll-cleaved fragments are indicated on the right; BamHI fragments are shown on the left with capital letters as in Fig, 1. :81~ (Kim & Yates, 1993; Longnecker et aI., 1992 Longnecker et aI., , 1993a but our experiments suggest that LMP2 greatly influences the efficiency of this process. The current approaches to studying immortalizing EBV genes are limited since they rely on recombination of an endogenous EBV with plasmid DNA to yield a mixed virus stock; the different members of this cannot be sorted other than through the successful immortalization of B lymphocytes. Clearly, such an approach does not allow ready measurement of quantitatively distinct contributions to the process of B cell immortalization in vitro as documented by our experiment with the LMP2-p40 construct. The analyses of the resulting immortalized B cell clones allow a statistical interpretation of numerical data which suggests a role of LMP2 in the process of B cell immortalization (Table 2 ). To solve this problem, we have developed mini-EBV plasmids to study the contributions of individual immortalizing genes to the efficiency of B cell immortalization.
Mini-EBV plasmids can carry all trans-acting functions required for immortalization and have been shown to initiate and maintain proliferation of B cells in the absence of any function provided by EBV helper virus (Kempkes et al., 1995a, b) . pI478.A is such a mini-EBV plasmid which encompasses ,-~ 70 kb of EBV, and B cell clones infected with such mini-EBVs are usually free of PdHR1 helper virus. The mini-EBV construct p68, which differs from p1478.A only in a mutated LMP2 locus (Fig. 3) , appears to be impaired in its capacity to initiate or maintain B cell immortalization efficiently. The majority of immortalized cells were found to be infected with p68 in conjunction with helper virus indicating that the mutation constitutes a disadvantage to B cell immortalization in vitro. Moreover, two cell clones which were infected with mini-EBV only had the defective LMP2 gene corrected by homologous recombination with the helper virus genome to compensate for the lack of a functional LMP2 gene.
The same LMP2 mutation was introduced into the context of the P3HR1 strain of EBV by single-site mutagenesis with p40 DNA. This attempt yieIded three B cell lines which carried the desired mutation but the majority of the cell lines were wild-type with respect to LMP2 by trans-complementing PdHR1 virus (Table 2 ). This observation is not unique and had been noted previously (Longnecker et al., 1993 a) but the aspect had not been pursued. It appears that functional LMP2 is advantageous, but not absolutely necessary, for the initiation or maintenance of B cell proliferation. Thus, the phenotype of the LMP2 gene is auxiliary and comparable with EBNA-LP (Hammerschmidt & Sugden, I989) .
Consistent with the phenotype of LMP2-mutants, LMP2A has been reported to function as a negative regulator of signal transduction in that it preserves the status of latency (Miller et a]., 1994b (Miller et a]., , 1995 . LMP2A blocks the changes of intracellular free calcium that otherwise result from cross-linking of cell surface immunoglobulins and limits tyrosine kinase activity of members of different protein kinase families (Miller et aL, 1995) . Conceivably, LMP2 mutant EBV would be expected to initiate and maintain B cell proliferation but these cells might be prone to enter the lyric phase of the EBV life-cycle. As a consequence, spontaneous activation of the lyric cycle would result in virus production accompanied by cell death and possible destruction of the immortalized cells. This model seems to be logical since the preservation of the latent state is a prerequisite for generation of stable B cell lines in vitro. However, B cell lines immortalized by p1478.A or p68 miniEBVs cannot enter the complete lytic cycle since most genes involved in lyric phase gene expression are missing with the exception of BZLF1 and BRLF1. In addition, LMP2-EBVinfected B cell clones show a very much reduced level of spontaneous induction of the lytic phase of the EBV life-cycle compared with cells immortalized by wild-type EBV (Miller et al., 1994 b) and B cell clones that stem from cord blood cells are completely refractory to this process (data not shown). It thus appears that the phenotype of LMP2-mutants in B cell immortalization relates to immortalizing functions yet to be defined.
